380 related articles for article (PubMed ID: 24706876)
41. NH2-terminal signals in ATP7B Cu-ATPase mediate its Cu-dependent anterograde traffic in polarized hepatic cells.
Guo Y; Nyasae L; Braiterman LT; Hubbard AL
Am J Physiol Gastrointest Liver Physiol; 2005 Nov; 289(5):G904-16. PubMed ID: 15994426
[TBL] [Abstract][Full Text] [Related]
42. The six metal binding domains in human copper transporter, ATP7B: molecular biophysics and disease-causing mutations.
Ariöz C; Li Y; Wittung-Stafshede P
Biometals; 2017 Dec; 30(6):823-840. PubMed ID: 29063292
[TBL] [Abstract][Full Text] [Related]
43. Structures of the human Wilson disease copper transporter ATP7B.
Yang GM; Xu L; Wang RM; Tao X; Zheng ZW; Chang S; Ma D; Zhao C; Dong Y; Wu S; Guo J; Wu ZY
Cell Rep; 2023 May; 42(5):112417. PubMed ID: 37074913
[TBL] [Abstract][Full Text] [Related]
44. Copper-induced apical trafficking of ATP7B in polarized hepatoma cells provides a mechanism for biliary copper excretion.
Roelofsen H; Wolters H; Van Luyn MJ; Miura N; Kuipers F; Vonk RJ
Gastroenterology; 2000 Sep; 119(3):782-93. PubMed ID: 10982773
[TBL] [Abstract][Full Text] [Related]
45. Intracellular trafficking of the human Wilson protein: the role of the six N-terminal metal-binding sites.
Cater MA; Forbes J; La Fontaine S; Cox D; Mercer JF
Biochem J; 2004 Jun; 380(Pt 3):805-13. PubMed ID: 14998371
[TBL] [Abstract][Full Text] [Related]
46. Role of the copper-binding domain in the copper transport function of ATP7B, the P-type ATPase defective in Wilson disease.
Forbes JR; Hsi G; Cox DW
J Biol Chem; 1999 Apr; 274(18):12408-13. PubMed ID: 10212214
[TBL] [Abstract][Full Text] [Related]
47. Copper transporting P-type ATPases and human disease.
Cox DW; Moore SD
J Bioenerg Biomembr; 2002 Oct; 34(5):333-8. PubMed ID: 12539960
[TBL] [Abstract][Full Text] [Related]
48. Haplotype and mutation analysis in Japanese patients with Wilson disease.
Nanji MS; Nguyen VT; Kawasoe JH; Inui K; Endo F; Nakajima T; Anezaki T; Cox DW
Am J Hum Genet; 1997 Jun; 60(6):1423-9. PubMed ID: 9199563
[TBL] [Abstract][Full Text] [Related]
49. Characterization of the Wilson disease gene encoding a P-type copper transporting ATPase: genomic organization, alternative splicing, and structure/function predictions.
Petrukhin K; Lutsenko S; Chernov I; Ross BM; Kaplan JH; Gilliam TC
Hum Mol Genet; 1994 Sep; 3(9):1647-56. PubMed ID: 7833924
[TBL] [Abstract][Full Text] [Related]
50. Wilson disease.
Harada M
Med Electron Microsc; 2002 Jun; 35(2):61-6. PubMed ID: 12181646
[TBL] [Abstract][Full Text] [Related]
51. Wilson disease-causing mutations in the carboxyl terminus of ATP7B regulates its localization and Golgi exit selectively in the unpolarized cells.
Chakraborty K; Das S; Pal A; Maji S; Rai B; Gupta A; Bhattacharjee A
Metallomics; 2023 Sep; 15(9):. PubMed ID: 37660282
[TBL] [Abstract][Full Text] [Related]
52. The role of the invariant His-1069 in folding and function of the Wilson's disease protein, the human copper-transporting ATPase ATP7B.
Tsivkovskii R; Efremov RG; Lutsenko S
J Biol Chem; 2003 Apr; 278(15):13302-8. PubMed ID: 12551905
[TBL] [Abstract][Full Text] [Related]
53. Wilson disease protein ATP7B utilizes lysosomal exocytosis to maintain copper homeostasis.
Polishchuk EV; Concilli M; Iacobacci S; Chesi G; Pastore N; Piccolo P; Paladino S; Baldantoni D; van IJzendoorn SC; Chan J; Chang CJ; Amoresano A; Pane F; Pucci P; Tarallo A; Parenti G; Brunetti-Pierri N; Settembre C; Ballabio A; Polishchuk RS
Dev Cell; 2014 Jun; 29(6):686-700. PubMed ID: 24909901
[TBL] [Abstract][Full Text] [Related]
54. ATP7B (WND) protein.
Terada K; Schilsky ML; Miura N; Sugiyama T
Int J Biochem Cell Biol; 1998 Oct; 30(10):1063-7. PubMed ID: 9785470
[TBL] [Abstract][Full Text] [Related]
55. Biochemical basis of regulation of human copper-transporting ATPases.
Lutsenko S; LeShane ES; Shinde U
Arch Biochem Biophys; 2007 Jul; 463(2):134-48. PubMed ID: 17562324
[TBL] [Abstract][Full Text] [Related]
56. p.H1069Q mutation in ATP7B and biochemical parameters of copper metabolism and clinical manifestation of Wilson's disease.
Gromadzka G; Schmidt HH; Genschel J; Bochow B; Rodo M; Tarnacka B; Litwin T; Chabik G; Członkowska A
Mov Disord; 2006 Feb; 21(2):245-8. PubMed ID: 16211609
[TBL] [Abstract][Full Text] [Related]
57. Effect of the toxic milk mutation (tx) on the function and intracellular localization of Wnd, the murine homologue of the Wilson copper ATPase.
La Fontaine S; Theophilos MB; Firth SD; Gould R; Parton RG; Mercer JF
Hum Mol Genet; 2001 Feb; 10(4):361-70. PubMed ID: 11157799
[TBL] [Abstract][Full Text] [Related]
58. Mutation analysis and characterization of alternative splice variants of the Wilson disease gene ATP7B.
Wan L; Tsai CH; Hsu CM; Huang CC; Yang CC; Liao CC; Wu CC; Hsu YA; Lee CC; Liu SC; Lin WD; Tsai FJ
Hepatology; 2010 Nov; 52(5):1662-70. PubMed ID: 20931554
[TBL] [Abstract][Full Text] [Related]
59. Comparative features of copper ATPases ATP7A and ATP7B heterologously expressed in COS-1 cells.
Liu Y; Pilankatta R; Hatori Y; Lewis D; Inesi G
Biochemistry; 2010 Nov; 49(46):10006-12. PubMed ID: 20964302
[TBL] [Abstract][Full Text] [Related]
60. Clusterin (apolipoprotein J), a molecular chaperone that facilitates degradation of the copper-ATPases ATP7A and ATP7B.
Materia S; Cater MA; Klomp LW; Mercer JF; La Fontaine S
J Biol Chem; 2011 Mar; 286(12):10073-83. PubMed ID: 21242307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
